At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Application of a Novel Synbiotic to Modulate the Human Gut Microbiota and Improve Health
In Brief
A clinical study evaluating Bifidobacteria adolescentis BD1, Bifidobacteria animalis subsp. lactis BB-12, and 4 other interventions for Intestinal Microbiota and Barrier Function. Completed, enrolled 151 participants across 1 site.
Detailed Summary
This study evaluates the effect of a dietary supplement to improve gut health. The participants will take one of six dietary treatments for three weeks, and the gut bacteria and the gut intestinal barrier will be assessed to determine if these dietary treatments beneficially change these markers of gut health.
Study Details
Timeline
Interventions
packet containing 10\^9 cells of Bifidobacteria adolescentis BD1
packet containing 10\^9 cells of Bifidobacteria animalis subsp. lactis BB-12
packet containing 10\^9 cells Bifidobacteria adolescentis BD1 and 5 g galactooligosaccharide
packet containing 10\^9 cells B animalis subsp. lactis BB-12 and 5 g galactooligosaccharide
5 g galactooligosaccharide
lactose powder, 5 grams